NEOADJUVANT IMMUNOTHERAPY

Clinical trials for NEOADJUVANT IMMUNOTHERAPY explained in plain language.

Never miss a new study

Get alerted when new NEOADJUVANT IMMUNOTHERAPY trials appear

Sign up with your email to follow new studies for NEOADJUVANT IMMUNOTHERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 4 Not yet finished but already full! 1

New drug combo shows promise against advanced cervical cancer in early trial

Disease control Ongoing

This study tests whether adding the immunotherapy drug QL1706 to standard chemotherapy before surgery can improve outcomes for people with locally advanced cervical cancer. About 54 participants will receive the combination, then have surgery to remove the tumor. Researchers will…

Matched conditions: NEOADJUVANT IMMUNOTHERAPY

Phase: PHASE2 • Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Disease control

Last updated May 13, 2026 16:03 UTC

NEOADJUVANT IMMUNOTHERAPY

Get alerted when new NEOADJUVANT IMMUNOTHERAPY trials appear

New drug combo shows promise against advanced cervical cancer in early trial